Search results
Moderna says FDA will not complete review of RSV vaccine by May 12 deadline
Market Watch· 2 hours agoThe FDA cited administrative constraints for the delay, Cambridge, Mass.-based Moderna said in a...
AstraZeneca withdrawing Covid vaccine, months after admitting rare side effect
The Telegraph via Yahoo News· 3 days agoThe Oxford-AstraZeneca Covid vaccine is being withdrawn worldwide, months after the pharmaceutical...
Novavax Soars on $1.2 Billion Sanofi Vaccine Licensing Deal
Bloomberg via Yahoo Finance· 2 hours agoInc. shares surged after the company signed a $1.2 billion licensing agreement with Sanofi that...
France’s Sanofi in COVID-19 vaccine deal with Novavax
WSAU Wausau· 7 hours agoPARIS (Reuters) - Sanofi on Friday announced it has reached a licensing agreement with Novavax to...
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 4 days agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
AstraZeneca withdraws Covid-19 vaccine, citing low demand | CNN Business
CNN.com· 2 days agoThe vaccine — called Vaxzevria and developed in partnership with the University of Oxford — has been...
Was COVID vaccine recalled over health danger fears? What we know
Newsweek· 1 day agoPharmaceutical company AstraZeneca has initiated a global withdrawal of its COVID-19 vaccine just...
AstraZeneca pulls its COVID-19 vaccine from Europe
Boston Herald· 16 hours agoAstraZeneca’s COVID-19 vaccine was first given the nod by the EMA in January 2021.
Moderna Announces Update on Investigational RSV Vaccine
The Joplin Globe· 2 hours agoThe FDA has informed Moderna that it is working to conclude...
Novavax's license deal with Sanofi at lofty valuation sends shares soaring
Reuters· 2 hours ago, opens new tab for COVID-19 vaccines in exchange for a stake that valued the U.S. biotech firm at...